Inactive Instrument

Sector Chart Basilea Pharmaceutica AG Xetra

Equities

PK5

CH0011432447

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
44.87B -
37.8B
37.61B
31.32B -
27.4B